United Therapeutics Corp. (UTHR)
577.58
-0.96
(-0.17%)
USD |
NASDAQ |
Apr 15, 16:00
577.83
+0.25
(+0.04%)
Pre-Market: 20:00
United Therapeutics Research and Development Expense (Quarterly) : 139.50M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| MannKind Corp. | 27.59M |
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| Insmed, Inc. | 254.91M |
| Johnson & Johnson | 4.268B |
| Eli Lilly & Co. | 3.802B |